Rui Tada, Hidehiko Suzuki, Miki Ogasawara, Daisuke Yamanaka, Yoshiyuki Adachi, Jun Kunisawa, & Yoichi Negishi. (2021). Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation against <i>Streptococcus pneumoniae</i> Infections in Mice. MDPI AG.
Chicago Style (17th ed.) CitationRui Tada, Hidehiko Suzuki, Miki Ogasawara, Daisuke Yamanaka, Yoshiyuki Adachi, Jun Kunisawa, and Yoichi Negishi. Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation Against <i>Streptococcus Pneumoniae</i> Infections in Mice. MDPI AG, 2021.
MLA (9th ed.) CitationRui Tada, et al. Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation Against <i>Streptococcus Pneumoniae</i> Infections in Mice. MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.